Peter Blume-Jensen

Director & President and CEO

Director & President and CEO at Acrivon Therapeutics, Inc., filing insider transactions between 2026-08-18 and 2026-08-25.

Total Purchases

—

0 transactions

Total Sales

$34K

3 transactions

Companies Traded

3 total filings

Active Since

2026-08-18

Last: 2026-08-25

Companies

Acrivon Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-25	ACRV	Sale	14.0K	$2.21	$31K	2.23M	SEC ↗
2026-08-18	ACRV	Sale	1,229	$2.01	$2K	2.24M	SEC ↗
2026-08-18	ACRV	Sale	484	$2.01	$973	385.9K